Will some day PAPS fade into SLE?

Lupus

Volumn 5, Issue 1, 1996, Pages 4-5

  Cabral, A R ^a   Alarcon Segovia D ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; HUMAN; NOTE; PATHOPHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIPHOSPHOLIPID SYNDROME; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0030076766     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500102     Document Type: Editorial

References (18)

1. Alarcón-Segovia D., Sánchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989; 16: 482-489.
2. Alarcón-Segovia D. et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. 1989; Medicine 68: 353-365.
3. Amigo MC, Garcia-Torres R., Robles M., Bochicchio T., Reyes PA Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992, 19: 1181-1185.
4. Alarcón-Segovia D., Pérez-Vázquez ME, Villa AR, Drenkard C., Cabiedes J. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 275-286.
5. Derksen Rhwm, Gmeling-Meijling Fhj, de Groot PhG. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. Lupus 1996; 5: 77-80.
6. Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
7. Vianna JL et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 96: 3-9.
8. Cardiel MH, Cabral AR, Alarcón-Segovia D. Manuscript in preparation.
9. Mujic F., Cuadrado MJ, Lloyd M., Khamashta MA, Page G., Hughes Grv. Primary antiphospholipid syndrome evolving into systemic lupus erythematosus. J Rheumatol 1995; 22: 1589-1592.
10. Rivero SJ, Diaz-Jouanen E., Alarcón-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic and prognostic significance. Arthritis Rheum 1978; 21: 295-305.
11. Vargas-Alarcón G., Granados J., Bekker C., Alcocer-Varela J., Alarcón-Segovia D. Association of HLA-DR5 (possibly DRB1*1201) with the primary antiphospholipid syndrome in Mexican patients. Arthritis Rheum 1995; 38: 1340-1341.
12. Asherson RA, Doherty DG, Vergani D., Khamashta M., Hughes Grv. Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum 1992; 35: 124-125.
13. Khamashta MA, Cuadrado MJ, Mujic F., Taub NA, Hunt BJ, Hughes Grv. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997.
14. Alarcón-Segovia D., Sánchez-Guerrero J. Correction of thrombocytopenia with small dose aspirin in primary antiphospholipid syndrome. J Rheumatol 1989; 16: 1421-1427.
15. Asherson RA, Baguley E., Pal C., Hughes Grv. Antiphospholipid syndrome: 5 year follow-up. Ann Rheum Dis 1992; 50: 805-810.
16. Silver RM, Draper ML, Scott JR, Lyon JL, Reading J., Branch DW Clinical consequences of antiphospholipid antibodies: an historic cohort study. Obstet Gynecol 1994; 83: 327-377.
17. Andrews PA, Frampton G., Cameron JS Antiphospholipid syndrome and systemic lupus erythematosus. Lancet 1993, 342: 988-989.
18. Piette JC, Wechsler B., Frances C., Godeau P. Systemic lupus erythematosus and the antiphospholipid syndrome: reflections about the relevance of the ARA criteria. J Rheumatol 1992; 19: 1835-1837.